Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1590)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (51)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (54)
¹ÙÀÌ¿ÀÀåºñ (357)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (131)
À¯ÀüÀÚ Ä¡·á/RNAi (101)
Àç»ýÀÇÇÐ (124)
Ç×ü/¸é¿ª (191)
½ÃÀ庸°í¼­

Nucleic Acid Isolation Markets in Europe

¸®¼­Ä¡»ç Frost & Sullivan
¹ßÇàÀÏ 2006³â 06¿ù »óǰÄÚµå 45118
ÆäÀÌÁö Á¤º¸
°¡°Ý
US $ 6,500 £Ü 7,744,700 Web Access (Regional License)
US $ 7,000 £Ü 8,340,500 Hard Copy & Web Access (Regional License)


¿µ¹®¸ñÂ÷

Abstract

Research Overview

This analysis is available through our Drug Discovery Technologies Growth Partnership Service program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

To maximize the potential for growth within a firm's internal and external environment, Frost & Sullivan consultants can facilitate the creation of strategic programs that deliver improved market success. Frost & Sullivan's strengths lie in combining strategic understanding with market expertise and applying these with absolute commitment to its clients' growth.

Table of Contents

  • 1. Executive Summary
    • 1. Industry Snapshot
      • 1. Key Findings
  • 2. Glossary and Exchange Rates
    • 1. Glossary of Terms
      • 1. Terms
    • 2. Currency Exchange Rates
      • 1. Exchange Rates
  • 3. Total Nucleic Acid Isolation Market in Europe
    • 1. Market Overview
      • 1. Key Market Trends
    • 2. Research Methodology
      • 1. Research Service Methodology
    • 3. Segmentation
      • 1. Market Segmentation
    • 4. Market Engineering Measurements
      • 1. Market Engineering Measurements
    • 5. Industry Challenges
      • 1. Key Challenges
    • 6. Market Drivers
      • 1. Market Drivers
      • a. Need for More Sample Purity Spurs Market Growth
      • b. Emerging Trends in Translational Medicine Providing the Impetus for Nucleic Acid Isolation Protocols
      • c. Preconfigured Dedicated Solutions Aid Smaller Research Laboratories
      • d. RNA Extraction Markets Witnesses a Positive Growth Trend
    • 7. Market Restraints
      • 1. Market Restraints
      • a. Gearshift to Proteomics Approach Thwarts Nucleic Acid Penetration
      • b. Gradual Shift in the Application Pursuits Deter the Market for Nucleic Acid
      • c. Funding Insufficiencies and Some Anomalies in the Research Spending Cause Some Concern to the Suppliers
    • 8. Revenue Forecasts
      • 1. Revenue Forecasts
    • 9. Pricing Trends
      • 1. Key Pricing Trends
    • 10. Technology Trends
      • 1. Technology Trends
  • 4. Nucleic Acid Instrumentation Markets
    • 1. Market Engineering Measurements
      • 1. Market Engineering Measurements for the Instrumentation Segment
    • 2. Revenue Forecasts
      • 1. Revenue Forecasting Analysis
    • 3. Competitive Structure
      • 1. Competitive Landscape
  • 5. Nucleic Acid Consumables Market for Isolation
    • 1. Market Engineering Measurements
      • 1. Market Engineering Measurements for Consumables
    • 2. Revenue Forecasts
      • 1. Revenue Forecast Analysis
    • 3. Competitive Structure
      • 1. Competitive Landscape
  • 6. Strategic Recommendations
    • 1. Key Strategies
      • 1. Competitive Scenario Analysis and Strategies
  • 7. DSD for Nucleic Acid Isolation Markets
    • 1. Pharmaceutical R&D Expenditure
      • 1. Pharmaceuticals R&D Expenditure
    • 2. Pharmaceutical R&D Expenditure as a Percent of the Pharmaceutical Market
      • 1. Pharmaceuticals R&D Expenditure as a Percent of the Pharmaceuticals Market
    • 3. Number of Biotech Companies
      • 1. Number of Biotech Companies
    • 4. Private Investment in Biotechnology
      • 1. Private Investment in Biotechnology
    • 5. Government Investments in R&D
      • 1. Government Investments in R&D
  • 8. Database of Key Industry Participants
    • 1. Key Industry Participants
      • 1. List of Industry Participants in the European Nucleic Acid Isolation Market
Back to Top